Loading organizations...
Single-cell analysis for clinical diagnosis and drug development.
Singleron Biotechnologies has raised $30.0M across 1 funding round.
Singleron Biotechnologies has raised $30.0M in total across 1 funding round.
Singleron Biotechnologies has raised $30.0M in total across 1 funding round.
Singleron Biotechnologies's investors include Lilly Asia Ventures, ARCH Venture Partners, CDH Investments, Huachuang Capital, Sherpa Capital, Tencent.
Singleron Biotechnologies has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series A in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 6, 2020 | $30.0M Series A | Lilly Asia Ventures | ARCH Venture Partners, CDH Investments, Huachuang Capital, Sherpa Capital, Tencent |